Literature DB >> 4601222

Attenuated respiratory syncytial virus vaccines in asthmatic children.

K McIntosh, A M Arbeter, M K Stahl, I A Orr, D S Hodes, E F Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4601222      PMCID： PMC7086601          DOI： 10.1203/00006450-197407000-00001

Source DB:  PubMed          Journal:  Pediatr Res        ISSN： 0031-3998            Impact factor:   3.756


× No keyword cloud information.
  5 in total

1.  Viral infection as a precipitant of wheeze in children. Combined home and hospital study.

Authors:  I Mitchell; J M Inglis; H Simpson
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

2.  Growth and genetic stability of the ts-1 mutant of respiratory syncytial virus at restrictive temperatures.

Authors:  T J Schnitzer; L S Richardson; R M Chanock
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

3.  Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.

Authors:  Roderick S Tang; Mia MacPhail; Jeanne H Schickli; Jasmine Kaur; Christopher L Robinson; Heather A Lawlor; Jeanne M Guzzetta; Richard R Spaete; Aurelia A Haller
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 4.  Respiratory syncytial virus vaccines.

Authors:  R A Dudas; R A Karron
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

Review 5.  Bronchiolitis and asthma: possible common pathogenetic pathways.

Authors:  K McIntosh
Journal:  J Allergy Clin Immunol       Date:  1976-06       Impact factor: 10.793
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.